Eyal Breitbart

Eyal Breitbart is an experienced biotechnology executive, currently serving as Chief Technology Officer at Vidac Pharma since June 2025. Prior to this role, Eyal held the position of Chief Production Officer at Orgenesis Inc. from 2023 to June 2025, focusing on production system management and technological knowledge transfer. Eyal's extensive career at VBL Therapeutics, spanning from February 2001 to 2023, included roles as COO and VP of R&D, overseeing operational activities and leading R&D studies to clinical trials. Eyal's educational background includes a Postdoctoral Fellowship from Tufts University School of Medicine and a Ph.D. in Biochemistry, alongside a Master’s and Bachelor’s degree from Bar-Ilan University.